Ellagic acid as a potential antioxidant, alleviates methotrexate-induced hepatotoxicity in male rats

References

• Hersh EM, Wong VG, Henderson ES, et al. Hepatotoxic effects of methotrexate. Cancer. 1966;19:600–606.
   PubMed Web of Science ®Google Scholar
• Akbulut S, Elbe H, Eris C, et al. Cytoprotective effects of amifostine, ascorbic acid and N-acetylcysteine against methotrexate-induced hepatotoxicity in rats. World J Gastroenterol. 2014;20:10158–10165.
   PubMed Web of Science ®Google Scholar
• Pugh AJ, Barve AJ, Falkner K, et al. Drug-induced hepatotoxicity or drug-induced liver injury. Clin Liver Dis. 2009;13:277–294.
   PubMed Web of Science ®Google Scholar
• Uraz S, Tahan V, Aygun C, et al. Role of ursodeoxycholic acid in prevention of methotrexate-induced liver toxicity. Dig Dis Sci. 2008;53:1071–1077.
   PubMed Web of Science ®Google Scholar
• Hagner N, Joerger M. Cancer chemotherapy: targeting folic acid synthesis. Cancer Manag Res. 2010;2:293–301.
   PubMedGoogle Scholar
• Armagan I, Bayram D, Candan IA, et al. Effects of pentoxifylline and alpha lipoic acid on methotrexate-induced damage in liver and kidney of rats. Environ Toxicol Pharmacol. 2015;39:1122–1131.
   PubMed Web of Science ®Google Scholar
• Caetano NN, Campello AP, Carnieri EG, et al. Effect of methotrexate (MTX) on NAD(P)+ dehydrogenases of HeLa cells: malic enzyme, 2-oxoglutarate and isocitrate dehydrogenases. Cell Biochem Funct. 1997;15:259–264.
   PubMed Web of Science ®Google Scholar
• Tedeschi PM, Lin H, Gounder M, et al. Suppression of cytosolic NADPH pool by thionicotinamide increases oxidative stress and synergizes with chemotherapy. Mol Pharmacol. 2015;88:720–727.
   PubMed Web of Science ®Google Scholar
• Kirkman HN, Rolfo M, Ferraris AM, et al. Mechanisms of protection of catalase by NADPH kinetics and stoichiometry. J Biol Chem. 1999;274:13908–13914.
   PubMed Web of Science ®Google Scholar
• Ambrose SS, Solairaj P, Subramoniam A. Effectiveness of ellagic acid on isoniazid-rifampicin induced liver damage in rats. J Pharmacol Pharmacother. 2013;4:60–62.
   PubMedGoogle Scholar
• Pari L, Sivasankari R. Effect of ellagic acid on cyclosporine A-induced oxidative damage in the liver of rats . Fundam Clin Pharmacol. 2008;22:395–401.
   PubMed Web of Science ®Google Scholar
• Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev. 2009;2:270–278.
   PubMed Web of Science ®Google Scholar
• Priyadarsini KI, Khopde SM, Kumar SS, et al. Free radical studies of ellagic acid, a natural phenolic antioxidant. J Agric Food Chem. 2002;50:2200–2206.
   PubMed Web of Science ®Google Scholar
• Han DH, Lee MJ, Kim JH. Antioxidant and apoptosis-inducing activities of ellagic acid. Anticancer Res. 2006;26:3601–3606.
   PubMed Web of Science ®Google Scholar
• Lee W-J, Ou H-C, Hsu W-C, et al. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells. J Vasc Surg. 2010;52:1290–1300.
   PubMed Web of Science ®Google Scholar
• Barch DH, Rundhaugen LM, Stoner GD, et al. Structure-function relationships of the dietary anticarcinogen ellagic acid. Carcinogenesis. 1996;17:265–269.
   PubMed Web of Science ®Google Scholar
• Safaei F, Mehrzadi S, Khadem Haghighian H, et al. Protective effects of gallic acid against methotrexate-induced toxicity in rats. Acta Chir Belg. 2017[cited 2017 Oct 25]; [9 p.]. DOI:10.1080/00015458.2017.1394672
   Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.
   PubMed Web of Science ®Google Scholar
• Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 1957;28:56–63.
   PubMed Web of Science ®Google Scholar
• Belfield A, Goldberg D. Colorimetric determination of alkaline phosphatase activity. Enzyme. 1971;12:561–568.
   PubMedGoogle Scholar
• Goudarzi M, Kalantari H, Rezaei M. Glyoxal toxicity in isolated rat liver mitochondria. Hum Exp Toxicol. 2017[cited 2017 Jan 1]. DOI:10.1177/0960327117715900
   PubMed Web of Science ®Google Scholar
• Bradley PP, Priebat DA, Christensen RD, et al. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Investig Dermatol. 1982;78:206–209.
   PubMed Web of Science ®Google Scholar
• Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302–310.
   PubMedGoogle Scholar
• Guevara I, Iwanejko J, Dembińska-Kieć A, et al. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin Chim Acta. 1998;274:177–188.
   PubMed Web of Science ®Google Scholar
• Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82:70–77.
   PubMed Web of Science ®Google Scholar
• Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121–126.
   PubMed Web of Science ®Google Scholar
• Martin JP, Jr. Dailey M, Sugarman E. Negative and positive assays of superoxide dismutase based on hematoxylin autoxidation. Arch Biochem Biophys. 1987;255:329–336.
   PubMed Web of Science ®Google Scholar
• Johnston JA, Johnson ES, Waller PR, et al. Methotrexate inhibits proteolysis of dihydrofolate reductase by the N-end rule pathway. J Biol Chem. 1995;270:8172–8178.
   PubMed Web of Science ®Google Scholar
• Najafzadeh H, Rezaie A, Masoodi A, et al. Comparison of the effect of vanadium and deferoxamine on acetaminophen toxicity in rats. Indian J Pharmacol. 2011;43:429.
   PubMed Web of Science ®Google Scholar
• Hadi NR, Al-Amran FG, Swadi A. Metformin ameliorates methotrexate-induced hepatotoxicity. J Pharmacol Pharmacother. 2012;3:248–253.
   PubMedGoogle Scholar
• Ozer J, Ratner M, Shaw M, et al. The current state of serum biomarkers of hepatotoxicity. Toxicology. 2008;245:194–205.
   PubMed Web of Science ®Google Scholar
• Abo-Haded HM, Elkablawy MA, Al-Johani Z, et al. Hepatoprotective effect of sitagliptin against methotrexate induced liver toxicity. PloS One. 2017;12:e0174295.
   PubMed Web of Science ®Google Scholar
• Dalaklioglu S, Genc G, Aksoy N, et al. Resveratrol ameliorates methotrexate-induced hepatotoxicity in rats via inhibition of lipid peroxidation. Hum Exp Toxicol. 2013;32:662–671.
   PubMed Web of Science ®Google Scholar
• Curtis JR, Beukelman T, Onofrei A, et al. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide. Ann Rheum Dis. 2010;69:43–47.
   PubMed Web of Science ®Google Scholar
• Hussein RH, Khalifa FK. The protective role of ellagitannins flavonoids pretreatment against N-nitrosodiethylamine induced-hepatocellular carcinoma. Saudi J Biol Sci. 2014;21:589–596.
   PubMed Web of Science ®Google Scholar
• Girish C, Pradhan S. Hepatoprotective activities of picroliv, curcumin, and ellagic acid compared to silymarin on carbon-tetrachloride-induced liver toxicity in mice. J Pharmacol Pharmacother. 2012;3:149.
   PubMedGoogle Scholar
• Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis. 2005;15:316–328.
   PubMed Web of Science ®Google Scholar
• Dalle-Donne I, Rossi R, Giustarini D, et al. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003;329:23–38.
   PubMed Web of Science ®Google Scholar
• Gressier B, Lebegue S, Brunet C, et al. Pro-oxidant properties of methotrexate: evaluation and prevention by an anti-oxidant drug. Pharmazie. 1994;49:679–681.
   PubMed Web of Science ®Google Scholar
• Tabassum H, Parvez S, Pasha ST, et al. Protective effect of lipoic acid against methotrexate-induced oxidative stress in liver mitochondria. Food Chem Toxicol. 2010;48:1973–1979.
   PubMed Web of Science ®Google Scholar
• Öktem F, Yilmaz HR, Ozguner F, et al. Methotrexate-induced renal oxidative stress in rats: the role of a novel antioxidant caffeic acid phenethyl ester. Toxicol Ind Health. 2006;22:241–247.
   PubMed Web of Science ®Google Scholar
• Birben E, Sahiner UM, Sackesen C, et al. Oxidative stress and antioxidant defense. World Allergy Organ J. 2012;5:9–19.
   PubMedGoogle Scholar
• Fukai T, Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal. 2011;15:1583–1606.
   PubMed Web of Science ®Google Scholar
• Umar S, Ahmad S, Katiyar CK, et al. Combination therapy of methotrexate with ellagic acid attenuates the over expression of pro-inflammatory cytokines and modulates antioxidant status in collagen induced arthritis [Abstract]. Front Immunol. doi: 10.3389/conf.fimmu.2013.02.00795. [English].
   Google Scholar
• Devipriya N, Sudheer AR, Vishwanathan P, et al. Modulatory potential of ellagic acid, a natural plant polyphenol on altered lipid profile and lipid peroxidation status during alcohol‐induced toxicity: a pathohistological study. J Biochem Mol Toxicol. 2008;22:101–112.
   PubMed Web of Science ®Google Scholar
• Devipriya N, Srinivasan M, Sudheer A, et al. Effect of ellagic acid, a natural polyphenol, on alcohol-induced prooxidant and antioxidant imbalance: a drug dose dependent study. Singapore Med J. 2007;48:311–318.
   PubMedGoogle Scholar
• Ghaznavi H, Fatemi I, Kalantari H, et al. Ameliorative effects of gallic acid on gentamicin-induced nephrotoxicity in rats. J Asian Nat Prod Res. 2017[cited 2017 Oct 5]; [12 p.]. DOI:10.1080/10286020.2017.1384819
   Web of Science ®Google Scholar
• Jahovic N, Çevik H, Şehirli AÖ, et al. Melatonin prevents methotrexate‐induced hepatorenal oxidative injury in rats. J Pineal Res. 2003;34:282–287.
   PubMed Web of Science ®Google Scholar
• Carlsen H, Myhrstad MC, Thoresen M, et al. Berry intake increases the activity of the gamma-glutamylcysteine synthetase promoter in transgenic reporter mice . J Nutr. 2003;133:2137–2140.
   PubMed Web of Science ®Google Scholar
• Holley AK, Bakthavatchalu V, Velez-Roman JM, et al. Manganese superoxide dismutase: guardian of the powerhouse. Int J Mol Sci. 2011;12:7114–7162.
   PubMed Web of Science ®Google Scholar
• Chao P-c, Hsu C-c, Yin M-c. Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice. Nutr Metab (Lond). 2009;6:33.
   PubMed Web of Science ®Google Scholar
• Şener G, Ekşioğlu-Demiralp E, Cetiner M, et al. L-Carnitine ameliorates methotrexate-induced oxidative organ injury and inhibits leukocyte death. Cell Biol Toxicol. 2006;22:47–60.
   PubMed Web of Science ®Google Scholar
• Mansouri MT, Hemmati AA, Naghizadeh B, et al. A study of the mechanisms underlying the anti-inflammatory effect of ellagic acid in carrageenan-induced paw edema in rats. Indian J Pharmacol. 2015;47:292–298.
   PubMed Web of Science ®Google Scholar
• Takamatsu Y, Shimada K, Yamaguchi K, et al. Inhibition of inducible nitric oxide synthase prevents hepatic, but not pulmonary, injury following ischemia-reperfusion of rat liver. Dig Dis Sci. 2006;51:571–579.
   PubMed Web of Science ®Google Scholar
• Cure E, Kirbas A, Tumkaya L, et al. Protective effect of infliximab on methotrexate-induced liver injury in rats: Unexpected drug interaction. J Cancer Res Ther. 2015;11:164–169.
   PubMed Web of Science ®Google Scholar
• Leitão RF, Brito GA, Oriá RB, et al. Role of inducible nitric oxide synthase pathway on methotrexate-induced intestinal mucositis in rodents. BMC Gastroenterol. 2011;11:90.
   PubMed Web of Science ®Google Scholar
• Erdogan E, Ilgaz Y, Gurgor PN, et al. Rutin ameliorates methotrexate induced hepatic injury in rats. Acta Cir Bras. 2015;30:778–784.
   PubMed Web of Science ®Google Scholar